4-Methyl-2,5-methoxyphenylcyclopropylamine

4-Methyl-2,5-methoxyphenylcyclopropylamine
Names
IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
Properties
C12H17NO2
Molar mass 207.27 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

DMCPA, or 4-methyl-2,5-methoxyphenylcyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

See also


  1. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.